193 related articles for article (PubMed ID: 31434474)
1. Repurposing Eukaryotic Kinase Inhibitors as Colistin Adjuvants in Gram-Negative Bacteria.
Barker WT; Nemeth AM; Brackett SM; Basak AK; Chandler CE; Jania LA; Zuercher WJ; Melander RJ; Koller BH; Ernst RK; Melander C
ACS Infect Dis; 2019 Oct; 5(10):1764-1771. PubMed ID: 31434474
[TBL] [Abstract][Full Text] [Related]
2. Structure-Function Studies on IMD-0354 Identifies Highly Active Colistin Adjuvants.
Nemeth AM; Basak AK; Weig AW; Marrujo SA; Barker WT; Jania LA; Hendricks TA; Sullivan AE; O'Connor PM; Melander RJ; Koller BH; Melander C
ChemMedChem; 2020 Jan; 15(2):210-218. PubMed ID: 31756025
[TBL] [Abstract][Full Text] [Related]
3. Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteria.
Barker WT; Martin SE; Chandler CE; Nguyen TV; Harris TL; Goodell C; Melander RJ; Doi Y; Ernst RK; Melander C
Bioorg Med Chem; 2017 Oct; 25(20):5749-5753. PubMed ID: 28958847
[TBL] [Abstract][Full Text] [Related]
4. Eukaryotic phosphatase inhibitors enhance colistin efficacy in gram-negative bacteria.
Barker WT; Jania LA; Melander RJ; Koller BH; Melander C
Chem Biol Drug Des; 2020 Nov; 96(5):1180-1186. PubMed ID: 32562384
[TBL] [Abstract][Full Text] [Related]
5. Synergistic combinations of anthelmintic salicylanilides oxyclozanide, rafoxanide, and closantel with colistin eradicates multidrug-resistant colistin-resistant Gram-negative bacilli.
Domalaon R; Okunnu O; Zhanel GG; Schweizer F
J Antibiot (Tokyo); 2019 Aug; 72(8):605-616. PubMed ID: 31028351
[TBL] [Abstract][Full Text] [Related]
6. Tryptamine derivatives disarm colistin resistance in polymyxin-resistant gram-negative bacteria.
Barker WT; Chandler CE; Melander RJ; Ernst RK; Melander C
Bioorg Med Chem; 2019 May; 27(9):1776-1788. PubMed ID: 30898435
[TBL] [Abstract][Full Text] [Related]
7. The Anthelmintic Drug Niclosamide Synergizes with Colistin and Reverses Colistin Resistance in Gram-Negative Bacilli.
Domalaon R; De Silva PM; Kumar A; Zhanel GG; Schweizer F
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917988
[TBL] [Abstract][Full Text] [Related]
8. Simple Dipyrrin Analogues of Prodigiosin for Use as Colistin Adjuvants.
Siwawannapong K; Nemeth AM; Melander RJ; Rong J; Davis JR; Taniguchi M; Carpenter ME; Lindsey JS; Melander C
ChemMedChem; 2022 Aug; 17(16):e202200286. PubMed ID: 35704751
[TBL] [Abstract][Full Text] [Related]
9. Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance.
Harris TL; Worthington RJ; Hittle LE; Zurawski DV; Ernst RK; Melander C
ACS Chem Biol; 2014 Jan; 9(1):122-7. PubMed ID: 24131198
[TBL] [Abstract][Full Text] [Related]
10. Second-Generation Meridianin Analogues Inhibit the Formation of Mycobacterium smegmatis Biofilms and Sensitize Polymyxin-Resistant Gram-Negative Bacteria to Colistin.
Zeiler MJ; Melander RJ; Melander C
ChemMedChem; 2020 Sep; 15(17):1672-1679. PubMed ID: 32662926
[TBL] [Abstract][Full Text] [Related]
11. Effects of Efflux Pump Inhibitors on Colistin Resistance in Multidrug-Resistant Gram-Negative Bacteria.
Ni W; Li Y; Guan J; Zhao J; Cui J; Wang R; Liu Y
Antimicrob Agents Chemother; 2016 May; 60(5):3215-8. PubMed ID: 26953203
[TBL] [Abstract][Full Text] [Related]
12. Reversion of antibiotic resistance in multidrug-resistant pathogens using non-antibiotic pharmaceutical benzydamine.
Liu Y; Tong Z; Shi J; Jia Y; Deng T; Wang Z
Commun Biol; 2021 Nov; 4(1):1328. PubMed ID: 34824393
[TBL] [Abstract][Full Text] [Related]
13. Activity of the type I signal peptidase inhibitor MD3 against multidrug-resistant Gram-negative bacteria alone and in combination with colistin.
Personne Y; Curtis MA; Wareham DW; Waite RD
J Antimicrob Chemother; 2014 Dec; 69(12):3236-43. PubMed ID: 25134721
[TBL] [Abstract][Full Text] [Related]
14. Benzimidazole Isosteres of Salicylanilides Are Highly Active Colistin Adjuvants.
Li H; Mattingly AE; Jania LA; Smith R; Melander RJ; Ernst RK; Koller BH; Melander C
ACS Infect Dis; 2021 Dec; 7(12):3303-3313. PubMed ID: 34752055
[TBL] [Abstract][Full Text] [Related]
15. Efflux pump inhibitor CCCP to rescue colistin susceptibility in mcr-1 plasmid-mediated colistin-resistant strains and Gram-negative bacteria.
Baron SA; Rolain JM
J Antimicrob Chemother; 2018 Jul; 73(7):1862-1871. PubMed ID: 29718423
[TBL] [Abstract][Full Text] [Related]
16. Drug Repurposing to Fight Colistin and Carbapenem-Resistant Bacteria.
Peyclit L; Baron SA; Rolain JM
Front Cell Infect Microbiol; 2019; 9():193. PubMed ID: 31245302
[TBL] [Abstract][Full Text] [Related]
17. Colistin: Revival of an Old Polymyxin Antibiotic.
Dijkmans AC; Wilms EB; Kamerling IM; Birkhoff W; Ortiz-Zacarías NV; van Nieuwkoop C; Verbrugh HA; Touw DJ
Ther Drug Monit; 2015 Aug; 37(4):419-27. PubMed ID: 25549206
[TBL] [Abstract][Full Text] [Related]
18. Polymyxin B: similarities to and differences from colistin (polymyxin E).
Kwa A; Kasiakou SK; Tam VH; Falagas ME
Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
[TBL] [Abstract][Full Text] [Related]
19. Comparison of antibacterial activities of polymyxin B and colistin against multidrug resistant Gram negative bacteria.
Doymaz MZ; Karaaslan E
Infect Dis (Lond); 2019 Sep; 51(9):676-682. PubMed ID: 31298061
[No Abstract] [Full Text] [Related]
20. Ultra-fast and universal detection of Gram-negative bacteria in complex samples based on colistin derivatives.
Ryu JS; Im SH; Kang YK; Kim YS; Chung HJ
Biomater Sci; 2020 Apr; 8(8):2111-2119. PubMed ID: 31967117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
